Back
Atara Biotherapeutics Vs. NeuroBo Pharmaceuticals Industry Stock Comparison
Sell
20
ATRA
Atara Biotherapeutics
Last Price:
8.03
Seasonality Move:
-9.83%
Sell
26
NRBO
NeuroBo Pharmaceuticals
Last Price:
3.25
Seasonality Move:
-38.71%
Sell
20
Atara Biotherapeutics (ATRA)
is a Sell
Is Atara Biotherapeutics a Buy, Sell or Hold?
- The current Atara Biotherapeutics [ATRA] share price is $8.08. The Score for ATRA is 20, which is 60% below its historic median score of 50, and infers higher risk than normal.
- ATRA is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
26
NeuroBo Pharmaceuticals (NRBO)
is a Sell
Is NeuroBo Pharmaceuticals a Buy, Sell or Hold?
- The current NeuroBo Pharmaceuticals [NRBO] share price is $3.32. The Score for NRBO is 26, which is 48% below its historic median score of 50, and infers higher risk than normal.
- NRBO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
ATRA Stock Price Chart
What is Atara Biotherapeutics's stock price today?
-
The Atara Biotherapeutics share price today is $8.08
The current trend is relatively stagnant and ATRA is experiencing slight buying pressure.
NRBO Stock Price Chart
What is NeuroBo Pharmaceuticals's stock price today?
-
The NeuroBo Pharmaceuticals share price today is $3.32
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NRBO is experiencing buying pressure, which is a positive indicator for future bullish movement.
ATRA Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.15 | Sell |
| Relative Strength Index (14 RSI): | 49.9 | Sell |
| Chaikin Money Flow: | 21080 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (7.13 - 8.91) | Buy |
| Bollinger Bands (100): | (7.24 - 13.32) | Sell |
NRBO Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.13 | Sell |
| Relative Strength Index (14 RSI): | 42.81 | Sell |
| Chaikin Money Flow: | 30825 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (3.26 - 3.68) | Sell |
| Bollinger Bands (100): | (3.54 - 4.44) | Sell |
ATRA Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 7.71 | Buy |
| 20-day SMA: | 8.27 | Sell |
| 50-day SMA: | 8.33 | Sell |
| 200-day SMA: | 13.79 | Sell |
| 8-day EMA: | 7.84 | Buy |
| 20-day EMA: | 8.01 | Buy |
| 50-day EMA: | 8.62 | Sell |
| 200-day EMA: | 17.17 | Sell |
NRBO Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 3.28 | Buy |
| 20-day SMA: | 3.48 | Sell |
| 50-day SMA: | 3.7 | Sell |
| 200-day SMA: | 4.05 | Sell |
| 8-day EMA: | 3.33 | Sell |
| 20-day EMA: | 3.44 | Sell |
| 50-day EMA: | 3.67 | Sell |
| 200-day EMA: | 5.68 | Sell |
Atara Biotherapeutics Earnings Growth & ATRA Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.28 per share, an increase next quarter of $8.28 per share, an increase this year of $42.84 per share, and a decrease next year of $64.80 per share.
NeuroBo Pharmaceuticals Earnings Growth & NRBO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Atara Biotherapeutics Technical Analysis
| Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
NeuroBo Pharmaceuticals Technical Analysis
| Sep 16 | Sep 17 | Sep 18 | Sep 19 | Sep 20 | Sep 23 | Sep 24 | Sep 25 | Sep 26 | Sep 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep | ||||||||||
| 16 | 17 | 18 | 19 | 20 | 23 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||